公开(公告)号：US11083762B2

公开(公告)日：2021-08-10

申请号：US15845394

申请日：2017-12-18

Applicant: Industrial Technology Research Institute

Inventor： I-Hong Pan ,  Wei-Hsuan Hsu ,  Chu-Hsun Lu ,  Shu-Fang Wen ,  Hsin-Chieh Wu

IPC: A61K36/04 ,  A61K35/744 ,  A61K8/9789 ,  A61Q19/08 ,  A61K35/747 ,  A23L33/105 ,  A23L33/00 ,  A61P25/28 ,  A61P25/22 ,  A61P25/24 ,  A61K35/00

Abstract: The present disclosure provides a method for treating and/or alleviating nervous diseases, including: administering an effective amount of a water extract of a plant of Gracilariaceae or a ferment thereof to a subject in need thereof to treat and/or alleviate a nervous disease thereof, wherein the ferment of the water extract of a plant of Gracilariaceae is a lactic acid bacteria ferment.

公开(公告)号：US09603882B2

公开(公告)日：2017-03-28

申请号：US14323719

申请日：2014-07-03

Applicant: Industrial Technology Research Institute

Inventor： I-Horng Pan ,  Shu-Fang Wen ,  Ming-Han Li ,  Hsin-Jan Yao ,  Hsin-Chieh Wu ,  I-Huang Lu ,  Joung-Liang Lan ,  Der-Yuan Chen ,  Chi-Chien Lin ,  Ching Lu

IPC: A61K36/06 ,  A61K36/07

CPC classification number: A61K36/07

Abstract: The disclosure provides a method for modulating Th17 cells, including: administering an Antrodia cinnamomea (also named Antrodia camphorata or Taiwanofungus camphoratus) extract to a subject in need thereof, wherein the Antrodia cinnamomea extract has an effect of modulating Th17 cells. The Antrodia cinnamomea extract may include a fruiting body extract of Antrodia cinnamomea or a mycelium extract of Antrodia cinnamomea.

公开(公告)号：US09682062B2

公开(公告)日：2017-06-20

申请号：US14133213

申请日：2013-12-18

Applicant: Industrial Technology Research Institute

Inventor： I-Horng Pan ,  Hsin-Jan Yao ,  Mei-Wei Lin ,  I-Huang Lu ,  Hsin-Chieh Wu ,  Hsiang-Wen Tseng ,  Ching-Huai Ko ,  Chun-Chung Wang ,  Zong-Keng Kuo ,  Shyh-Horng Lin ,  Yi-Cheng Cheng ,  Tien-Soung Tong

IPC: A61K36/15 ,  A61K36/185 ,  A61K31/365 ,  A61K36/14 ,  A61K31/7048

CPC classification number: A61K31/365 ,  A61K31/7048 ,  A61K36/14 ,  A61K2300/00

Abstract: The disclosure provides a pharmaceutical composition for inhibiting angiogenesis, including an effective amount of an extract of Juniperus chinensis or an effective amount of a lignan as an effective ingredient. The pharmaceutical composition may further include a pharmaceutically acceptable carrier or salt. The disclosure also provides a method for inhibiting angiogenesis, including administering an effective amount of an extract of Juniperus chinensis or an effective amount of a lignan as an effective ingredient for inhibiting angiogenesis to a subject in need thereof.